Ameritas Investment Partners’s KALA BIO KALA Stock Holding History

Ameritas Investment Partners’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	-$5K	–	3152
2022 Q1	$5K	Hold	1	–	–	﹤0.01%	2967
2021 Q4	$4K	Hold	1	–	–	﹤0.01%	3059
2021 Q3	$9K	Hold	1	–	–	﹤0.01%	2965
2021 Q2	$19K	Hold	1	–	–	﹤0.01%	2763
2021 Q1	$24K	Hold	1	–	–	﹤0.01%	2484
2020 Q4	$24K	Hold	1	–	–	﹤0.01%	2384
2020 Q3	$26K	Hold	1	–	–	﹤0.01%	2237
2020 Q2	$37K	Buy	+1	New	+$28.3K	﹤0.01%	2011
2020 Q1	–	Hold	0	–	–	–	2497
2019 Q4	–	Hold	0	–	–	–	2920
2019 Q3	–	Hold	0	–	–	–	2930
2019 Q2	–	Hold	0	–	–	–	2862
2019 Q1	–	Hold	0	–	–	–	2694
2018 Q4	–	Hold	0	–	–	–	2819
2018 Q3	–	Hold	0	–	–	–	2765
2018 Q2	–	Hold	0	–	–	–	2594
2018 Q1	–	Hold	0	–	–	–	2449
2017 Q4	–	Hold	0	–	–	–	2656

Other funds holding KALA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ameritas Investment Partners's KALA Position: Q2 2022 in Review

Ameritas Investment Partners sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 1 share — an estimated $5K sold.

Ameritas Investment Partners first reported a position in KALA in Q2 2020 and held it in 8 quarters. The position peaked at $37K in Q2 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

Ameritas Investment Partners reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 1 KALA BIO share in Q2 2022, an estimated $5K.
Ameritas Investment Partners first reported a position in KALA BIO in Q2 2020 and held it in 8 quarters.
Ameritas Investment Partners's KALA BIO position peaked at $37K in Q2 2020.
63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.